[DOI] [PMC free article] [PubMed] [Google Scholar] 134.Altun E., Avci E., Yildirim T., Yildirim S
E-Posters - ACUTE ISCHEMIC STROKE MANAGEMENT 01.00 - ACUTE ISCHEMIC STROKE MANAGEMENT - 01.05 - NEUROINTERVENTION P2059 - ESOC25-1092 SAFETY AND EFFECTIVENESS OF ENDOVASCULAR TREATMENT VERSUS MEDICAL MANAGEMENT IN LATE-PRESENTING LARGE ISCHEMIC STROKE Trung Nguyen 1 , Khang Nguyen 2 , Hang Tran 3 , Binh Pham 1 , Anh Truong 1,3 , Thien Le 4 , Lanh Nguyen 5 , Dung Bach 2 , Vu Tran 6 , Tra Le 6 , Huy Quang Dang 1 , Hung Dang 7 , Bang Phan 8 , BA-Thang Nguyen 2,9 , Thang Nguyen 1,3 1 Department of Cerebrovascular Disease, 115 Peoples Hospital, Ho Chi Minh, Viet Nam, 2 University Medical Center of HCMC, Vietnam, Ho Chi Minh, Viet Nam, 3 Pham Ngoc Thach University of Medicine, Ho Chi Minh, Viet Nam, 4 Stroke Department, Da Nang Hospital, Da Nang, Viet Nam, 5 Stroke Center, Can Tho central Hospital, Can Tho, Viet Nam, 6 Department of Neurointervention, 115 Peoples Hospital, Ho Chi Minh, Viet Nam, 7 Department of Neurology, Trung Vuong Hospital, Ho Chi Minh, Viet Nam, 8 Department of Internal Medicine, Buon Ma Thuot University Medical Hospital, Buon Ma Thuot, Viet Nam, 9 Ho Chi Minh City Medicine and Pharmacy University, Ho Chi Minh, Viet Nam Background and Aims: Evidence for endovascular treatment (EVT) in large-core ischemic stroke within the late window (624 hours) is limited
Selective orthosteric free fatty acid receptor 2 (FFA2) agonists: Identification of the structural and chemical requirements for selective activation of FFA2 versus FFA3
Semaglutide is best suited for people with significant weight to lose, typically those with a BMI of 30 or higher, or 27 or higher with weight-related health conditions
Inhibition of GSK3 promotes serine/1 C metabolism and exhibits a significant synergistic effect with SHIN1 in suppressing the proliferation of lung cancer cells [1]
